Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Popp

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Biomedicines|November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery CohortJin Xu, Rebecca Green, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayLiu Shi, Sarah Westwood, Alison L Baird, et al.
Acta Neuropathologica|March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentLuca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
Journal of Alzheimer'S Disease : JAD|August 25, 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease PathologyLiu Shi, Laura M Winchester, Benjamine Y Liu, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Biomedicines|November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery CohortJin Xu, Rebecca Green, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayLiu Shi, Sarah Westwood, Alison L Baird, et al.
Acta Neuropathologica|March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentLuca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
Journal of Alzheimer'S Disease : JAD|August 25, 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease PathologyLiu Shi, Laura M Winchester, Benjamine Y Liu, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Pageof 16